Article

PSA doubling of <3 months points to eventual death

Chicago-A post-treatment PSA doubling time less than 3 months followingeither surgery or radiation for localized or locally advanced prostate cancercan be a surrogate marker for eventual-perhaps inevitable-death from thedisease, according to data from a multicenter study of nearly 9,000 cancerpatients.

Related Videos
Petar Bajic, MD, answers a question during a video interview
Ellen Cahill, MD, answers a question during a video interview
1 KOL is featured in this series.
1 KOL is featured in this series.
Raevti Bole, MD, answers a question during a video interview
Denise Asafu-Adjei, MD, MPH, answers a question during a video interview
Amy Pearlman, MD, answers a question during a video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.